TOPADUR Pharma AG, located in Schlieren, was founded in 2015 by experienced R&D scientists. TOPADUR discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to treat aging-related diseases as chronic wounds, glaucoma, colorectal cancer, hair loss and skin aging.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business